Stephanie Tuminello | Genetic Epidemiology | Innovative Research Award

 

Innovative Research Award

Stephanie Tuminello
Icahn School of Medicine at Mount Sinai

Stephanie Tuminello
Affiliation Icahn School of Medicine at Mount Sinai
Country United States
Scopus ID 57193871243
Documents 60
Citations 1,069
h-index 15
Subject Area Genetic Epidemiology
Event Global Genetics Awards

Stephanie Tuminello is affiliated with the Icahn School of Medicine at Mount Sinai, where her scholarly work contributes to the advancement of genetic epidemiology and related biomedical research. Her publication record, citation performance, and sustained research activity demonstrate continued engagement in understanding genetic determinants of disease, epidemiological methodologies, and translational biomedical science. Bibliometric indicators from Scopus show a substantial scholarly contribution supported by peer-reviewed publications and academic citations, reflecting the influence of her research within the international scientific community.[1]

Abstract

Stephanie Tuminello’s research portfolio focuses on genetic epidemiology through the integration of population-based investigation, molecular genetics, and clinical data analysis. Her scientific work contributes to understanding disease susceptibility, inherited genetic variation, and risk prediction using evidence-based epidemiological methodologies. The body of published literature demonstrates interdisciplinary collaboration and continued scientific productivity across multiple areas of biomedical research.[1]

Keywords

Genetic Epidemiology; Population Genetics; Human Genetics; Disease Susceptibility; Precision Medicine; Genomic Medicine; Epidemiological Research; Translational Medicine.

Introduction

Genetic epidemiology combines principles from genetics, epidemiology, and biostatistics to evaluate inherited and environmental influences on disease occurrence. Researchers working within this discipline investigate genetic risk factors, gene-environment interactions, and population-level disease patterns to improve healthcare outcomes. Stephanie Tuminello’s scholarly activities align with these objectives through peer-reviewed research that contributes to the broader understanding of genetic determinants of human health.[2]

Research Profile

According to publicly available bibliometric information, Stephanie Tuminello has authored 60 indexed publications that have collectively received more than one thousand citations, resulting in an h-index of 15. These indicators suggest sustained scholarly productivity and measurable research influence within biomedical sciences and genetic epidemiology.[1]

  • Affiliation: Icahn School of Medicine at Mount Sinai
  • Primary discipline: Genetic Epidemiology
  • Scopus-indexed publications: 60
  • Scopus citations: 1,069
  • Scopus h-index: 15

Research Contributions

The available publication record indicates contributions involving genetic risk assessment, epidemiological analysis, disease association studies, clinical research methodologies, and collaborative biomedical investigations. Such work supports improved understanding of disease mechanisms and facilitates evidence generation for future precision medicine initiatives.[1][3]

  • Population-based genetic investigations.
  • Clinical and translational epidemiological research.
  • Genetic susceptibility and disease association studies.
  • Interdisciplinary collaboration across biomedical sciences.

Publications

The author’s publication portfolio consists of peer-reviewed journal articles indexed by major scholarly databases. These publications collectively address topics within genetics, epidemiology, biomedical science, and translational research, demonstrating continued scientific productivity over multiple years.[1]

  • Research articles indexed in Scopus.
  • Collaborative multidisciplinary publications.
  • Biomedical and genetic epidemiology studies.

Research Impact

Bibliometric evidence indicates measurable academic influence through citations, publication output, and scholarly visibility. Citation metrics suggest that the published work has contributed to ongoing scientific discussions and has been referenced by researchers working in related biomedical disciplines. Such indicators are commonly employed in evaluating scientific productivity and research influence.[1]

Award Suitability

Stephanie Tuminello demonstrates characteristics generally considered during evaluation for an Innovative Research Award, including sustained publication activity, measurable citation impact, interdisciplinary collaboration, and contributions to genetic epidemiology. Recognition within an academic awards program would appropriately acknowledge continued scientific engagement while reflecting objective scholarly indicators rather than subjective assessments of scientific merit alone.[1]

Conclusion

Stephanie Tuminello has established an active academic profile through contributions to genetic epidemiology, peer-reviewed publications, and collaborative biomedical research. Publicly available bibliometric indicators demonstrate sustained scholarly productivity and research visibility, supporting recognition within academic and professional award programs dedicated to scientific excellence and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Stephanie Tuminello, Author ID 57193871243.
    Scopus.https://www.scopus.com/authid/detail.uri?authorId=57193871243
  2. Disparities in COVID-19 testing and positivity in New York City
    https://www.sciencedirect.com/science/article/pii/S0749379720302634
  3. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
    https://www.nature.com/articles/ncomms14922
  4. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City
    https://journal.chestnet.org/article/S0012-3692(20)34288-4/fulltext
  5. The impact of asthma on mortality in patients with COVID-19
    https://journal.chestnet.org/article/S0012-3692(20)31645-7/fulltext

 

Dongli Pan | Herpesvirus Infection | Best Researcher Award

Prof. Dr. Dongli Pan | Herpesvirus Infection | Best Researcher Award

Zhejiang University School of Medicine | China

Dr. Prof. Dongli Pan is a distinguished biochemist whose research has significantly advanced the understanding of viral pathogenesis and host-virus interactions. She earned her Ph.D. in Biochemistry from the University of Pennsylvania, Philadelphia (2001–2007), where her dissertation focused on the fast kinetics of tRNA movement on the ribosome during bacterial translation elongation, following a B.S. in Chemistry from Peking University, Beijing (1997–2001). Currently a Professor at the Zhejiang University School of Medicine, Dr. Pan’s major research interests center on the mechanisms of herpes simplex virus (HSV) infection and pathogenesis, HSV-host interactions, and anti-HSV drug development. Her research excellence has been recognized through several competitive national grants, including major projects funded by the National Key R&D Project of China and the National Natural Science Foundation of China, with total funding exceeding several million RMB. Dr. Pan has led and contributed to groundbreaking studies on viral latency, host microRNAs, and innate immune responses to DNA viruses. Before joining Zhejiang University, she conducted postdoctoral research at Harvard Medical School and the University of Pennsylvania, deepening her expertise in molecular virology. In addition to her research, Dr. Pan is a dedicated educator, actively involved in undergraduate and graduate teaching at Zhejiang University and the Zhejiang University–University of Edinburgh Institute, where she organizes and lectures in courses such as Infection 3, Pathogens, and Medical Microbiology and Parasitology, fostering the next generation of biomedical scientists through her bilingual instruction and mentorship.

Profiles: Scopus

Featured Publications

"Inhibitory effect of Alantolactone against varicella-zoster virus in vitro", Virology JournalThis link is disabled., 2025.

"A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing",Nature CommunicationsThis link is disabled., 2025.

"Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication", Journal of Medicinal Chemistry, 2025.

"Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells", J. Virol, 2025.

Dina Jiesisibieke | Reproductive Health | Best Researcher Award

Ms. Dina Jiesisibieke | Reproductive Health | Best Researcher Award

Peking University Third Hospital | China

Author Profile

Scopus

Google Scholar

📌 DINA JIESISIBIEKE, M.D. CANDIDATE

🏥 CLINICAL MEDICINE AT PEKING UNIVERSITY THIRD HOSPITAL Peking University

🎓 EARLY ACADEMIC PURSUITS

Dina Jiesisibieke embarked on her medical journey at Peking University Third Hospital, where she has been pursuing a Doctor of Medicine (M.D.) degree since 2019. With an impressive GPA of 3.7/4.0, she has consistently demonstrated academic excellence and dedication to the field of clinical medicine. Her early academic years were marked by outstanding achievements, securing multiple scholarships and honors for her exceptional performance.

🏆 PROFESSIONAL ENDEAVORS

Beyond her academic pursuits, Dina has actively engaged in research and international exchange programs. In 2023, she participated in an exchange program at Mahidol University, where she gained hands-on experience in plastic surgery. This international exposure has broadened her clinical expertise and provided her with a global perspective on medical practices.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON REPRODUCTIVE HEALTH

Dina's research primarily focuses on reproductive medicine, specifically evaluating reproductive outcomes of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Her work was recognized at the prestigious American Society for Reproductive Medicine (ASRM) conference in 2023, where she submitted a research abstract detailing her cohort study on reproductive outcomes.

🌍 IMPACT AND INFLUENCE

Dina's contributions extend beyond academic excellence, as she actively participates in scholarly discourse and medical research. Her involvement in clinical studies and international exchange programs positions her as an emerging leader in the medical field. Through her dedication to medical research and clinical training, she continues to inspire and set a benchmark for aspiring medical professionals.

📚 ACADEMIC CITATIONS

Her research has been recognized at a high level, with a conference abstract submitted to the American Society for Reproductive Medicine. This recognition highlights her growing influence in reproductive medicine and her commitment to contributing valuable insights to the medical community.

🏅 SCHOLARSHIPS AND AWARDS

Dina has been the recipient of numerous prestigious scholarships and awards, recognizing her academic excellence and dedication:

  • Merit Student of Peking University
  • Peking University Southwest Associated University Guan Yanhui Medical Education Scholarship (2019-2021)
  • Model Student of Academic Records of Peking University (2020-2024)
  • Peking University Weicai Pharmaceutical Scholarship (2021-2022)

🌟 LEGACY AND FUTURE CONTRIBUTIONS

As an aspiring physician, Dina Jiesisibieke is committed to advancing the field of clinical medicine and reproductive health. Her contributions to research, combined with her strong academic foundation and clinical experience, set the stage for a promising career in medicine. With continued dedication, she is poised to make a lasting impact in the field of reproductive medicine and beyond.

📑NOTABLE PUBLICATIONS 

"Prevalence of eye and adnexal disorders among elderly inmates in Taiwan prisons

  • Authors: C., Tsai, Chingyao , Z.L., Jiesisibieke, Zhu Liduzi , P., Tao, Ping , C., Chien, Chingwen , T., Tung, Taohsin
  • Journal: BMC Public Health
  • Year: 2024